Dorzox

Dorzox is an ophthalmic solution containing Dorzolamide, a carbonic anhydrase inhibitor. It is used to reduce high pressure inside the eye caused by open-angle glaucoma or ocular hypertension, thereby helping to prevent vision loss.

Dosage by Body Weight

Usually instilled as one drop in the affected eye(s) three times a day. Consult an ophthalmologist for precise instructions.

  1. Body Weight
    Below 5 kg
    Dose
    Not routine
    Frequency
    Use only if prescribed
    Tracking Notes
    Safety and efficacy in pediatric patients below 2 years have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not routine
    Frequency
    Use only if prescribed
    Tracking Notes
    Ophthalmic preparation; not dosed by body weight.
  3. Body Weight
    8-10 kg
    Dose
    Not routine
    Frequency
    Use only if prescribed
    Tracking Notes
    Ophthalmic preparation; not dosed by body weight.
  4. Body Weight
    11-15 kg
    Dose
    Not routine
    Frequency
    Use only if prescribed
    Tracking Notes
    Ophthalmic preparation; not dosed by body weight.
  5. Body Weight
    16-20 kg
    Dose
    Not routine
    Frequency
    Use only if prescribed
    Tracking Notes
    Ophthalmic preparation; not dosed by body weight.

Formulation

Eye Drops

Purpose

Lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Generic Name

Dorzolamide

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.